Health in Americas (WHO region) 171 indicators covering health for Americas (WHO region). IndicatorLatest Year10-yr change Rank ndx - number of people dying between ages x and x+n 1,129 2021 down 19.6% 7th Cases started on MDR-TB treatment 5,225 2024 up 49.9% 11th Raised fasting blood glucose (>=7.0 mmol/L) 8.3 2014 up 12.2% 8th Raised fasting blood glucose (>= 7.0 mmol/L) 8.9 2014 up 21.9% 4th Reported number of people requiring interventions against NTDs 39.16 million 2024 down 20.9% 6th Births attended by skilled health personnel 97.0% 2025 up 1.0% 3rd Percentage of total deaths due to NCDs overall and percentage of 9.96 2019 down 11.4% 7th Low birth weight prevalence 9.2% 2020 up 2.2% 9th Inactivated first-dose polio vaccine (IPV1) immunization coverage 91.0% 2025 up 26.4% 4th Low birth weight number 1,272 2020 down 7.3% 11th Number of current cigarette smokers, estimate 77.71 million 2030 down 19.2% 4th Reported number of children receiving antiretroviral therapy 17,000 2025 down 15.0% 3rd New or unknown treatment history cases: Pulmonary, bacteriologically 172,133 2023 up 31.1% 9th Number of children aged 6-59 months with anaemia 12,070 2019 down 20.2% 9th Prevalence of anaemia in children aged 6-59 months 16.5% 2019 down 17.1% 10th HIV-positive TB patients on ART (antiretroviral therapy) 68.0% 2024 up 4.6% 10th Treatment success rate for patients treated for MDR-TB 60.0% 2022 up 5.3% 11th Treatment success rate: HIV-positive TB cases 55 2023 up 3.8% 10th Polio vaccine: inactivated second or third-dose polio vaccine (IPVc) 85.0% 2025 — 3rd International Health Regulations core capacity scores, SPAR version 50 2025 — 6th Number of reported cases of poliomyelitis by wild poliovirus 0 2023 — 3rd Estimated number of malaria deaths 504 2024 up 44.8% 6th Number of prevalent tuberculosis cases 350,000 2014 down 14.6% 11th Estimated malaria incidence 4.26 2024 up 27.3% 4th Estimated malaria mortality rate 0.3238 2024 up 32.1% 5th Number of pregnant women living with HIV who received antiretrovirals 21,000 2025 down 16.0% 3rd Neonates protected at birth against neonatal tetanus (PAB) 94.0% 2022 up 10.6% 3rd Percentage of people living with HIV who know their HIV status 88 2025 up 18.9% 2nd Percentage of people living with HIV who know their status receiving 81 2025 up 11.0% 4th Tuberculosis - new and relapse cases 218,328 2011 down 5.2% 10th Estimated number of pregnant women living with HIV needing 30,000 2025 down 11.8% 3rd Total number of notified TB cases 228,460 2014 down 8.4% 11th Estimated number of pregnant women living with HIV 72 2025 up 1.4% 4th Smear-positive tuberculosis treatment-success rate 78.0% 2011 up 13.0% 8th Insufficiently active 80.67 2016 down 1.0% 8th Number of presumed malaria cases 0 2021 — 6th Number of indigenous malaria cases 478,396 2021 up 8.0% 6th Number of confirmed malaria cases 524,015 2021 up 9.5% 6th Total number of malaria cases 524,015 2021 up 9.5% 6th Yellow fever vaccine (YFV) immunization coverage among 1-year olds 67.0% 2025 up 21.8% 3rd Number of indigenous P. falciparum malaria cases 96,008 2021 down 6.1% 6th Preterm birth rate 9.14 2020 up 0.9% 10th Preterm birth 1.27 million 2020 down 8.1% 11th Percentage of people living with HIV receiving treatment who have 94 2025 up 10.6% 5th Number of malaria positive cases by rapid diagnostic test 140,023 2021 up 544.8% 6th Treatment success rate: XDR-TB cases 61 2022 up 110.3% 8th Confirmed cases of MDR-TB 2,967 2012 down 33.0% 10th Number of indigenous P. vivax malaria cases 334,713 2021 up 5.8% 3rd Number of people protected from malaria by indoor residual spraying 2.41 million 2021 down 39.4% 5th HIV-positive TB patients on CPT (co-trimoxazole preventive therapy) 52.0% 2014 up 8.3% 10th Confirmed cases of MDR-TB started treatment for MDR-TB 92.0% 2012 — 2nd ← Previous Page 3 of 3